Progesterone transdermal - Transdermal Delivery SolutionsAlternative Names: Progesterone spray - Transdermal Delivery Solutions; Progesterone TDS®
Latest Information Update: 27 May 2016
At a glance
- Originator Transdermal Delivery Solutions Corp
- Class Hormonal contraceptives; Hormonal replacements; Infertility therapies; Pregnenediones; Small molecules
- Mechanism of Action Progesterone receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Menopausal syndrome; Premenstrual syndrome